Analysis of barriers in psoriasis care from the patient's and the physician's perspective and generation of scientific data on the quality of health care in Denmark, Poland, Spain, and Germany
Cross-sectional, non-interventional study on healthcare for psoriasis in patients and their treating physicians. Clinical data on severity as well as subjective estimates on disease burden, quality of life etc. will be collected. Data collection is planned at multiple, representative sites in fourEuropean countries with different healthcare systems with the aim to identify system-dependent and -independent barriers in guideline-compliant psoriasis care.
Study Type
OBSERVATIONAL
Enrollment
1,304
non-interventional survey study
Aarhus University Hospital
Aarhus, Denmark
Nationwide group of dermatological centers, hospitals and medical offices
Hamburg, Germany
Medical University of Poznan
Poznan, Poland
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Percentage of patients with severe disease receiving systemic treatment
Time frame: Baseline
Psoriasis Area and Severity Index (PASI)
Psoriasis disease severity, measured by validated instrument
Time frame: Baseline
Body Surface Area (BSA)
Psoriasis-affected body area, measured by physician estimate
Time frame: Baseline
Dermatology Life Quality Index (DLQI)
Quality of life assessment in dermatologic patients, measured by validated quality of life instrument
Time frame: Baseline
EuroQuol (EQ-5D)
generic quality of life assessment, measured by validated visual analogue scale
Time frame: Baseline
Percentage of patients with comorbidities receiving treatment.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.